Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Concentration enhancement" refers broadly to methods—pharmacological and non-pharmacological—that improve an individual's ability to focus attention on tasks. This concept encompasses strategies ranging from mental exercises and mindfulness practices to dietary supplements and prescription medications that modulate neurotransmitter systems involved in attention regulation. While many substances are marketed for their potential to enhance concentration—including nootropics like N-acetyl L-Tyrosine, citicoline, phosphatidylserine; herbal extracts like ginkgo biloba and ginseng; as well as caffeine—the term does not denote any single molecular entity or drug target. Instead it describes an outcome relevant across multiple domains of health and productivity.
Mechanisms by which drugs/supplements may enhance concentration include: Supporting catecholamine neurotransmitter activity (dopamine, norepinephrine); Enhancing acetylcholine signaling; Improving brain energy metabolism/ATP production; Increasing cerebral blood flow and oxygen delivery.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Concentration enhancement.